In line with these findings, treatment of mice with MASLD with a TNFα antibody for one week markedly diminished the increase in peripheral plasma ethanol levels and the loss of ADH activity in liver tissue. Here, TNF is linked to metabolic dysfunction-associated steatotic liver disease.